December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
Ahmed Shunt Versus Baerveldt Shunt for Refractory Glaucoma
Author Affiliations & Notes
  • V Khemsara
    Atlanta GA
  • AP Costarides
    Ophthalmology Emory University Atlanta GA
  • AD Beck
    Ophthalmology Emory University Atlanta GA
  • Footnotes
    Commercial Relationships   V. Khemsara, None; A.P. Costarides, None; A.D. Beck, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 3356. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      V Khemsara, AP Costarides, AD Beck; Ahmed Shunt Versus Baerveldt Shunt for Refractory Glaucoma . Invest. Ophthalmol. Vis. Sci. 2002;43(13):3356.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: To compare Baerveldt 350 and Ahmed S-2 implants in the treatment of glaucoma refractory to medical therapy. Methods: A retrospective review of 45 patients who underwent glaucoma shunt implantation by two surgeons (APC, ADB) from 1997-2001. Clnical data was tabulated pre and post operatively at day 1, 1 month, 6 months, and 1 year. Failure was defined as IOP ≷21 or <6 mm Hg at the most recent visit, progression to NLP, additional glaucoma surgery, or sight threatening complications. Results: Average IOPs (mmHg) for each shunt are shown below. Overall success rates were 76.2% for Ahmed implants and 87.5% for Baerveldt implants. Causes of failure for Ahmed patients were uncontrolled IOP (19%) and corneal decompensation (4.7%). For the Baerveldt implant the causes of failure were corneal decompensation (8.3%) and surgical intervention (4.2%). In addition 14.2% of Ahmed patients and 16.6% of Baerveldt patients had choroidal detachments. Conclusion: The Baerveldt implant had a higher success rate then the Ahmed implant at one year.  

Keywords: 503 outflow: trabecular meshwork 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.